BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

BRG.AU

29.5

+3.04%↑

Search

Fisher & Paykel Healthcare Corp Ltd

Cerrado

SectorInmobiliario

33.77 0.12

Resumen

Variación precio

24h

Actual

Mínimo

33.42

Máximo

34.13

Métricas clave

By Trading Economics

Ingresos

224M

377M

Ventas

329M

1.3B

P/B

Media del Sector

56.712

58.706

BPA

0.26

Rentabilidad por dividendo

1.15

Margen de beneficios

29.462

Empleados

7,384

EBITDA

379M

654M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+13.45% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

1.15%

5.81%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.4B

20B

Apertura anterior

33.65

Cierre anterior

33.77

Noticias sobre sentimiento de mercado

By Acuity

45%

55%

52 / 190 Clasificación en Real estate

Fisher & Paykel Healthcare Corp Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

28 may 2025, 22:28 UTC

Charlas de Mercado

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 abr 2025, 02:01 UTC

Charlas de Mercado

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 feb 2025, 21:55 UTC

Charlas de Mercado

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 feb 2025, 22:06 UTC

Charlas de Mercado

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov 2024, 21:55 UTC

Charlas de Mercado

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov 2024, 22:39 UTC

Charlas de Mercado

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 sept 2024, 23:56 UTC

Charlas de Mercado

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

Comparación entre iguales

Cambio de precio

Fisher & Paykel Healthcare Corp Ltd previsión

Precio Objetivo

By TipRanks

13.45% repunte

Estimación a 12 Meses

Media 38.347 AUD  13.45%

Máximo 42.1 AUD

Mínimo 35.9 AUD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fisher & Paykel Healthcare Corp Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

9 ratings

5

Comprar

4

Mantener

0

Vender

Sentimiento

By Acuity

52 / 190 Clasificación en Inmobiliario

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.